The roll-out of vaccine approvals has led to some confusion over what charges consumers might be asked to cover. This echoes the confusion previously discussed with respect to COVID-19 diagnostic and antibody test pricing. But consumers, providers, and others that will have any involvement with vaccine production, distribution, or administration should be aware that the Coronavirus Aid, Relief, and Economic Security (CARES) Act provides different rules for treatment (including testing) than it does for preventative care, like the recently approved vaccines.
More Posts
Ordering Out During the Pandemic: Surcharges and Delivery Fee Caps Might Be Here to Stay
California Price Gouging Update: Class Action Filed Against Restaurant Group
International Spotlight: Price Gouging Restrictions in Brazil Converging with U.S. Enforcement
When Emergencies Become De Rigueur
Alleged Price Gouging in the District of Columbia? Attorney General Racine Sets Sights on Local Business
A Test Costs What? Pricing and Reimbursing COVID-19 Tests
International Spotlight: Price Gouging Restrictions in China
Price Gouging and Bad Intent: How Much Does it Matter?
Price Gouging Restrictions Beyond the 50 States
Subscribe: Subscribe via RSS